Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Stroke. 2011 Aug 25;42(11):3163–3167. doi: 10.1161/STROKEAHA.110.608919

Table 2.

Day 90 mRS and EI (≥4 or 0) in all patients, patients treated and not treated with IV tPA (for statistical significance, please see multivariate analysis).

Early Improvement Yes No

All patients 183 441

90-day mRS 0–1 (%) 98 (53.6) 118 26.8)

2–6 85 (46.5) 323 (73.2)

tPA patients 112 200

90-day mRS 0–1 (%) 68 (60.7) 65 (32.5)

2–6 44 (39.3) 135 (67.5)

Placebo patients 71 241

90-day mRS 0–1 (%) 30 (42.3) 53 (22.0)

2–6 41 (57.8) 188 (78.0)